Jan 06, 2015 - DAVE GRAINGER AWARDED TWO LECTURES
Dave Grainger (Eccles Presidential Chair of Pharmaceutics and Pharmaceutical Chemistry was recently awarded two named lectures: 1) the “Dr. K.T. Dholakia” oration, “Challenges in translating antimicrobial technologies to orthopedic implants”, as part of the Bombay Orthopedic Society’s annual meeting in Mumbai, India, December 28, 2014, and the 58th Annual Edward T. Smith Orthopaedic Lectureship, “Biologics for Orthopaedics – Where Are We in 2014 and the Future?, University of Texas-Houston, Department of Orthopaedic Surgery, November 14, 2014.
Feb 24, 2015 - TRADITIONAL MEDICINES MAY INTERFERE WITH AIDS TREATMENTS: LOU BARROWS, PH.D.
For the 35 million people worldwide who are living with AIDS, antiretroviral therapies are lifesaving medicines that can slow or halt the disease. But in some developing countries where these drugs are most needed, culture can impact the effectiveness of treatment. Lou Barrows, Ph.D., professor of pharmacology and toxicology at the University of Utah, is investigating interactions between commonly used traditional medicines in Papua New Guinea and antiretroviral therapies for treating AIDS. He explains his research findings and how they could impact people in Papua New Guinea, as well as in the U.S.
Feb 25, 2015 - U.S. NEWS & WORLD REPORT RELEASES 2015 BEST GRADUATE SCHOOLS RANKINGS: U OF U COLLEGE OF PHARMACY #10
The U.S. News & World Report, a publisher of the Best Colleges rankings, released highlights of the 2015 Best Graduate Schools online. This year, once again, the University of Utah, College of Pharmacy ranked #10 on the nation. The 2015 edition includes rankings for five of the largest professional graduate school disciplines – business, law, education, engineering and medicine – as well as specialty rankings within each discipline. Read the rankings here and the article here.
Mar 08, 2015 - JOSHUA SCOTT CONARTON HAS BEEN SELECTED FOR THE 2015 OUTSTANDING UNDERGRADUATE STUDENT RESEARCHER
Joshua Scott Conarton has been selected for the 2015 Outstanding Undergraduate Student Researcher in the College of Pharmacy Award!
He, along with his faculty mentor Hamid Ghandehari, will be honored at the Undergraduate Research Awards Luncheon on March 31, 2015 @ 12:00PM.
Mar 30, 2015 - KYLE TURNER PUBLISHED ON PRIMARY CARE PROGRESS WEBSITE
Kyle Turner has been published on the Primary Care Progress website. The progress note describes the Utah PCP chapter and his role as president.
May 05, 2015 - BLOOD-THINNING BRIDGE THERAPY
Mar 24, 2015 - LOCAL PHARMACY IN THE FUTURE
How might your neighborhood pharmacy be different five or ten years from now? Dr. Mike Feehan, visiting professor in the College of Pharmacy at the University of Utah talks about how one day, you may be more likely to visit your local pharmacist for routine acute care than you would your doctor. He is conducting the largest survey of its kind to determine a new model for pharmacies that works best for consumers, pharmacists, and insurance providers. The research is being done in collaboration with Mark Munger, PharmD & Senior Associate Dean for College Affairs and is supported by the Skaggs Foundation for Research.
Mar 27, 2015 - ISPOR RESEARCH PRESENTATION PODIUM AND POSTER AWARDS
The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences. We are so excited and proud to display this award received by Adam Bress at this year’s annual international meeting. Nice work Adam!
Jun 03, 2015 - JMCP
Please join us in congratulating Carrie McAdam-Marx, Brandon Jennings, Mukul Singhal, and Karen Gunning on the publication of the research in JMCP.
Jun 29, 2015 - RHO CHI/PLS INDUCTION CEREMONY
Aug 04, 2015 - AMY BARRIOS HAS BEEN SELECTED AS A 2015 TEVA SCHOLAR
We are very excited to announce that Amy Barrios has been selected as a 2015 Teva Scholar! The Teva Pharmaceuticals Scholars program is administered by the ACS Office of Research Grants. The program is a philanthropic grant program that supports academic researchers in the fields of organic and medicinal chemistry. Only three awards are granted each year and we are very excited for Amy that she is one of the 2015 recipients. Please join us in congratulating Amy.
Aug 09, 2015 - CHRIS IRELAND APPOINTED AS THE ASIA CAMPUS CHIEF ADMINISTRATIVE OFFICER AND ASSOCIATE VICE PRESIDENT FOR RESEARCH
With the retirement of Dr. In Suk Han as President of its Asia Campus NPO, the University of Utah is announcing a new Senior Leadership Team in Incheon effective August 15th. In making this announcement, the University is re-emphasizing that the Asia Campus is a nationally accredited extended campus of the University of Utah. As such, degrees offered on the Asia campus meet U.S. national accreditation standards and comply with the requirements of the Utah System of Higher Education. All students attending the Asia Campus spend at least one year on the main campus in Salt Lake City; meet the same admissions and program degree requirements; are taught and mentored by qualified faculty appointed at the University of Utah; and will receive a University of Utah degree. To further emphasize the alignment of the Asia Campus as simply an extension of the University of Utah led by President David W. Pershing, the new Asia Campus senior administrator in Korea will no longer use the title “President”, but is appointed as the Chief Administrative Officer (CAO) and serve as President Pershing’s legal and administrative representative in Korea.
President Pershing and the Board of Directors for the University of Utah Asia Campus are pleased to announce the appointment of Dr. Chris Ireland as the Asia Campus Chief Administrative Officer and Associate Vice President for Research. Dr. Ireland is a University of Utah Distinguished Professor of Medicinal Chemistry and the former Dean of the College of Pharmacy. He is a researcher in the Experimental Therapeutics Program at the Huntsman Cancer Institute in Salt Lake City and has served as member of the National Cancer Institute Board of Scientific Counselors for Basic Sciences (2008-2013). Dr. Ireland received a bachelor's degree from the University of California, San Diego, and a PhD from Scripps Institution of Oceanography, San Diego.
Two nationally recognized leaders in student services and academic affairs will join Dr. Ireland on the Asia Campus Senior Leadership Team. Dr. Kari Ellingson comes to Korea from the main campus in Salt Lake City, and is currently University of Utah Associate Vice President for Student Development. She has been appointed as the Associate Vice President for Student Affairs at the U Asia Campus, along with faculty teaching responsibilities. Dr. Ellingson is an Adjunct Associate Professor in Education, Leadership and Policy, and the former Director of the University’s Counseling Center where she was also on staff as psychologist. She earned a Bachelor of Arts degree in English from the University of Virginia, a Master of Education in Counseling, and a Ph.D. in Counseling Psychology from the University of North Carolina at Chapel Hill.
Dr. Stephen Walston is a Professor of Public Health in School of Medicine at the University of Utah, and serves as the Asia Campus Vice President for Academic Affairs. Prior to coming to Korea, he served as a Professor and Associate Dean for Academic Affairs at the University of Oklahoma’s School of Public Health, Department of Health Administration and Policy for ten years. Dr. Walston earned a Ph.D. from the University of Pennsylvania’s Wharton School, and a master’s and bachelor’s degree from Brigham Young University. Dr. Walston specializes in healthcare strategy, organizational development, and leadership.
This new leadership team will be building on a solid foundation established this past year by the Asia campus faculty and staff, and the University of Utah administration in Salt Lake City. To further strengthen this foundation, the campus leadership is bringing together a Korean Advisory Council of business and education leaders, national and local government officials, NGO’s, and University of Utah alumni living in Korea who will work hand-in-hand with the Asia Campus to offer students the highest quality college experience available anywhere in the world, as well as develop a major research enterprise within Incheon and the Songdo International City. The Council will meet on a regular basis to provide input and recommendations on the vitality of the Asia Campus academic, student life, and research programs.
The University of Utah looks forward to continued success as the Asia Campus classes for the fall 2015 semester begin on August 31st under the new leadership.
Aug 17, 2015 - DAVID GRAINGER IS NAMED AS 2015 WILLIAM EVANS VISITING FACULTY FELLOW BY THE UNIVERSITY OF OTAGO, NEW ZEALAND
Faculty David Grainger is named as 2015 William Evans Visiting Faculty Fellow by the University of Otago, New Zealand. Grainger will spend several weeks in October, 2015 lecturing at the School of Medicine, School of Pharmacy, Centre for Bioengineering and Nanomedicine, and Centre for Innovation at the University of Otago, New Zealand. The William Evans fund of the University of Otago was established by the University Council in 1946 under the will of the late Dr William Evans, a well-known family physician in Dunedin, who died in 1943. He bequeathed the remainder of his estate to the University of Otago, which, on the recommendation of the Professorial Board is mainly devoted to financing a Visiting Professorship for the promotion and encouragement of learning. Fellowship awards are made by invitation from the University upon recommendation from the William Evans Selection Committee.
Oct 04, 2015 - DR. ICK CHAN KWON MENTIONED AS ONE OF SIXTEEN MOST CITED KOREAN RESEARCHERS IN KOREA TIMES
Department alumnus Ick Chan Kwon one of sixteen "Most Cited Researchers in Korea" as reported in the daily Korea Times newspaper.
Dr. Ick Chan Kwon is currently a tenured principal research scientist at the Biomedical Research Institute at the Korea Institute of Science and Technology (KIST). He received his B.S. and M.S. degrees from the College of Engineering at Seoul National University in 1982 and 1984, respectively.
He received his Ph.D. in pharmaceutics and pharmaceutical chemistry from the University of Utah, U.S.A., in 1993. After a postdoctoral training at the Center for Controlled Chemical Delivery at the University of Utah, he joined KIST in 1994.
He serves as an editor for Asia of the Journal of Controlled Release (Elsevier) and as a member of the editorial boards of Advanced Drug Delivery Reviews, Journal of Biomedical Engineering Research, and Journal of Biomaterials Science, Polymer Edition. He served as a program co-chair of the 37th Annual Meeting & Exposition of the Controlled Release Society, “Personalized Medicines and Products for the Next Generation,” which was held at Oregon Convention Center, Portland, OR, in 2010.
He also served as a vice president (2005–2008) and president (2008–2010) of the Korean Society of Molecular Imaging. His main research interest is targeted drug delivery with polymeric nanoparticles, expanding to the development of smart nano-probes for theragnostic imaging. He is a project leader of “Global RNAi Carrier Initiative at BRI” at KIST. He has published nearly 280 peer-reviewed articles and delivered over 100 invited lectures at international conferences.
Dec 31, 2015 - RANDALL T. PETERSON NEW DEAN OF THE COLLEGE OF PHARMACY
Randall T. Peterson, Ph.D., will assume his role as dean and L.S. Skaggs Presidential Endowed Chair for Pharmacy Jan. 1, 2017.
Peterson is a Salt Lake City native, he earned his undergraduate degree in molecular biology from Brigham Young University and his Ph.D. in biochemistry from Harvard University. He is the current Charles Addison and Elizabeth Ann Sanders Associate Professor of Basic Science at Harvard Medical School, scientific director of the Massachusetts General Hospital Cardiovascular Research Center and a senior associate member of the Broad Institute.
Peterson and his colleagues were the first to use an animal model, the zebrafish, to model human diseases and then rapidly identify small molecule drug candidates for cardiovascular and nervous system disorders. Several compounds discovered by his lab are used as research tools or are preclinical drug candidates.
Peterson is a principal investigator or co-investigator on numerous National Institutes of Health (NIH) research grants, including a current $12 million award from the National Institute of Neurological Disorders and Stroke to establish a Center of Excellence to develop novel pharmaceutical countermeasures for cyanide exposure. He was the principal investigator on a prestigious National Institute of Mental Health EUREKA grant to develop psychotropic drugs using zebrafish models. EUREKA grants encourage exceptionally innovative research to accelerate scientific progress.
An inventor on numerous patents, Dr. Peterson has served as a scientific advisor to companies including Montigen Pharmaceuticals Inc. and Tolero Pharmaceuticals, Inc. He is also involved in national conversations about the future of precision medicine, a key part of the University of Utah Health Sciences strategy to improve health care. Peterson recently co-chaired the second annual international Zebrafish for Personalized/Precision Medicine Conference.
The College of Pharmacy’s outstanding research and academic programs and the world-class reputation of the University of Utah Health Sciences as a whole made Utah an attractive place for Peterson to expand his research and academic career. Peterson’s expertise is well suited to lead the College of Pharmacy, which ranks fifth in the nation for NIH research funding.
"I am delighted to join the College of Pharmacy and the University’s effort to improve the lives of people in Utah and far beyond through pioneering research and clinical advances,” he said. “This mission is particularly close to my heart, and I look forward to working with my colleagues to continue the College of Pharmacy’s trajectory as a leading innovator in the research, teaching, and clinical practice of the pharmaceutical sciences.”
"Dr. Peterson is uniquely qualified to lead the College of Pharmacy to new heights of innovation as we work to develop personalized drug therapies,” said Health Sciences Senior Vice President Vivian Lee, M.D., Ph.D., M.B.A. “He is also well-prepared to train our students in the skills they will need to advance the clinical practice of pharmacy, ultimately improving the health of our communities."
Lee extended special thanks to Pharmacology and Toxicology Professor Kristen Keefe, Ph.D., for her service as our interim dean since June of 2014. Keefe has agreed to continue to serve until the end of 2016.
"We owe Dr. Keefe an enormous debt of gratitude for her skilled leadership and passionate dedication to the college," said Lee. "During her tenure, she has continued to drive the college forward, and the college's NIH funding ranks it among the top five in the nation. Dr. Keefe worked diligently and ably to lead the College in its development of both a strategic research and funding plan for the school."